Healthcare -
Biotechnology - NASDAQ - US
$ 1.5823
-1.11 %
$ 23.5 M
Market Cap
-0.28
P/E
LGVN - CAPITAL EXPENDITURES
Capital Expenditures LGVN - Longeveron Inc.
-694 K
LAST VALUE
27.21%
2 YEAR CAGR
-26.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR